Skip to main content

Galapagos N.V. (GLPG) Stock Forecast

Data as of Sep 20, 2026

Healthcare · Current price $27.75 ()

Consensus Target
$67.93
Upside
+144.8%
Analysts
1
Rating
Hold(3.00)

Price Target Range

Low $33.00Consensus $67.93High $97.00
▲ Current $27.75

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

GLPG vs Sector & Market

MetricGLPGHealthcare AvgLarge Cap Avg
Analyst Rating3.002.252.42
Analyst Count1818
Target Upside+144.8%+22243.6%+21.5%
P/E Ratio4.983.7638.34

Revenue Estimates

PeriodLowAvgHigh#
2027-03-31$8M$14M$26M1
2027-06-30$8M$14M$26M1
2027-09-30$8M$14M$26M1
2027-12-31$8M$14M$26M1
2028-03-31$8M$14M$26M1
2028-06-30$8M$14M$26M1
2028-09-30$8M$14M$26M1
2028-12-31$8M$14M$26M1

EPS Estimates

PeriodLowAvgHigh#
2027-03-31$-2.10$-1.00$-0.421
2027-06-30$-2.10$-1.00$-0.421
2027-09-30$-2.12$-1.01$-0.421
2027-12-31$-2.14$-1.02$-0.431
2028-03-31$-2.25$-1.07$-0.451
2028-06-30$-2.27$-1.08$-0.451
2028-09-30$-2.29$-1.09$-0.461
2028-12-31$-2.31$-1.10$-0.461

Frequently Asked Questions

What is the analyst consensus for GLPG?

The consensus among 1 analysts covering Galapagos N.V. (GLPG) is Hold with an average price target of $67.93.

What is the highest price target for GLPG?

The highest analyst price target for GLPG is $97.00.

What is the lowest price target for GLPG?

The lowest analyst price target for GLPG is $33.00.

How many analysts cover GLPG?

1 analysts have issued ratings for Galapagos N.V. in the past 12 months.

Is GLPG a buy or sell right now?

Based on 1 analyst ratings, GLPG has a consensus rating of Hold (3.00/5) with a +144.8% upside to the consensus target of $67.93.

What are the earnings estimates for GLPG?

Analysts estimate GLPG will report EPS of $-1.00 for the period ending 2027-03-31, with revenue estimated at $14M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.